Efficacy of Linvoseltamab in Prespecified High Risk Subgroups of Patients with Relapsed/Refractory Multiple Myeloma: Results from LINKER-MM1

被引：0

作者：

Suvannasankha, Attaya ^{[1
,2
]}

Lee, Hans ^{[3
]}

Bumma, Naresh ^{[4
]}

Dhodapkar, Madhav V. ^{[5
]}

Richter, Joshua ^{[6
]}

Hoffman, James E. ^{[7
]}

Shah, Mansi ^{[8
]}

Lentzsch, Suzanne ^{[9
]}

Zonder, Jeffrey ^{[10
]}

Baz, Rachid ^{[11
]}

Maly, Joseph J. ^{[12
]}

Namburi, Swathi ^{[13
]}

Wu, Ka Lung ^{[14
]}

Pianko, Matthew ^{[15
]}

Silbermann, Rebecca ^{[16
]}

Min, Chang-Ki ^{[17
]}

Vekemans, Marie-Christiane ^{[18
]}

Munder, Markus ^{[19
]}

Martinez Lopez, Joaquin ^{[20
]}

DeVeaux, Michelle ^{[21
]}

Chokshi, Dhruti ^{[21
]}

Boyapati, Anita ^{[21
]}

Kroog, Glenn S. ^{[21
]}

Houvras, Yariv ^{[21
]}

Jagannath, Sundar ^{[22
]}

机构：

[1] Indiana Univ, Simon Canc Ctr, Indianapolis, IN USA

[2] Roudebush VAMC, Indianapolis, IN USA

[3] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[4] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA

[5] Emory Univ, Sch Med, Atlanta, GA USA

[6] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[7] Univ Miami Hlth Syst, Miami, FL 33125 USA

[8] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA

[9] Columbia Univ, Med Ctr, New York, NY USA

[10] Karmanos Canc Inst, Detroit, MI 48201 USA

[11] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[12] Norton Canc Inst, Louisville, KY USA

[13] Swedish Canc Inst, Seattle, WA USA

[14] ZNA Cadix, Antwerp, Belgium

[15] Univ Michigan Hlth, Rogel Canc Ctr, Ann Arbor, MI USA

[16] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USA

[17] Catholic Univ Korea, St Marys Hosp, Seoul, South Korea

[18] Univ Catholic Louvain UCLouvain, Clin Univ St Luc, Dept Hematol, Brussels, Belgium

[19] Univ Med Ctr Mainz, Dept Internal Med 3, Mainz, Germany

[20] Univ Complutense, Hosp 12 Octubre, CNIO, Sch Med ,i 12, Madrid, Spain

[21] Regeneron Pharmaceut Inc, Tarrytown, NY USA

[22] Mt Sinai Med Ctr, New York, NY USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-084

引用

页码：S90 / S91

页数：2

共 50 条

[31] Efficacy and safety of elranatamab in patients with high-risk relapsed/refractory multiple myeloma (RRMM): A subgroup analysis from MagnetisMM-3
Larson, Sarah Marie
Bahlis, Nizar J.
Maisel, Christopher
Karlin, Lionel
Yanovsky, Asya Varshavsky
Leip, Eric
Sullivan, Sharon T.
Viqueira, Andrea
Touzeau, Cyrille
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[32] Safety and efficacy of bortezomib in high-risk and elderly patients with relapsed multiple myeloma
Richardson, Paul G.
Sonneveld, Pieter
Schuster, Michael W.
Irwin, David
Stadtmauer, Edward A.
Facon, Thierry
Harousseau, Jean-Luc
Ben-Yehuda, Dina
Lonial, Sagar
San Miguel, Jesus-F.
Cavenagh, Jamie D.
Anderson, Kenneth C.
BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 (05) : 429 - 435
[33] Venetoclax Monotherapy for Relapsed/Refractory Multiple Myeloma: Safety and Efficacy Results from a Phase I Study
Kumar, Shaji
Vij, Ravi
Kaufman, Jonathan L.
Mikhael, Joseph
Facon, Thierry
Pegourie, Brigitte
Benboubker, Lofti
Gasparetto, Cristina
Amiot, Martine
Moreau, Philippe
Alzate, Stefanie
Ross, Jeremy
Dunbar, Martin
Xu, Tu
Agarwal, Suresh
Leverson, Joel
Maciag, Paulo
Verdugo, Maria
Touzeau, Cyrille
BLOOD, 2016, 128 (22)
[34] Efficacy of Isatuximab with Pomalidomide and Dexamethasone in Elderly Patients with Relapsed/Refractory Multiple Myeloma: Icaria-MM Subgroup Analysis
Schjesvold, Fredrik H.
Richardson, Paul G.
Attal, Michel
Facon, Thierry
Alegre, Adrian
Spencer, Andrew
Jurczyszyn, Artur
Sunami, Kazutaka
Frenzel, Laurent
Min, Chang-Ki
Le-Guennec, Solenn
Campana, Frank
van de Velde, Helgi
Bensfia, Samira
Bringhen, Sara
BLOOD, 2019, 134
[35] Phase 1B Results of Ricolinostat (ACY-1215) Combination Therapy with Bortezomib and Dexamethasone in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma (MM)
Vogl, Dan T.
Raje, Noopur
Hari, Parameswaran
Jones, Simon S.
Supko, Jeffrey G.
Leone, Gina
Wheeler, Catherine
Orlowski, Robert Z.
Richardson, Paul G.
Lonial, Sagar
Tamang, David
Jagannath, Sundar
BLOOD, 2014, 124 (21)
[36] Content validity of the satisfaction and experience questionnaire (SEQ)-multiple myeloma (MM) among patients with relapsed/refractory multiple myeloma
Yucel, Emre
Skalicky, Anne
Eseyin, Olabimpe
Panjabi, Sumeet
QUALITY OF LIFE RESEARCH, 2019, 28 : S86 - S87
[37] Efficacy and Safety of Ruxolitinib and Steroids for Treating Patients with Relapsed or Refractory Multiple Myeloma
Berenson, James R.
Martinez, Daisy
Safaie, Tahmineh
Silagan, Noemi
To, Jennifer
Spektor, Tanya M.
Forouzan, Eli
Swift, Regina
Eades, Benjamin
Eshaghian, Shahrooz
Schwartz, Gary
Boccia, Ralph V.
Yang, Honghao H.
Moezi, Mehdi M.
Lim, Stephen
Vescio, Robert
BLOOD, 2021, 138
[38] Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myeloma
Suvannasankha, Attaya
Bahlis, Nizar
Trudel, Suzanne
Weisel, Katja
Koenecke, Christian
Oriol, Albert
Voorhees, Peter M.
Alonso, Aranzazu A.
Callander, Natalie S.
Mateos, Maria-Victoria
Reddy, Nishitha
Hakim, Shawn
Lamacchia, John
Patel, Nashita
Williams, Danae
Jewell, Roxanne. C.
Zhou, Xiangdong
Gupta, Ira
Opalinska, Joanna
Nooka, Ajay K.
CANCER, 2024, 130 (15) : 2629 - 2641
[39] Clinical Efficacy of Velcade/CTD Regimen in Patients with Relapsed or Refractory Multiple Myeloma
Kim, Y. K.
Lee, J. J.
Sohn, S. K.
Joo, Y. D.
Shin, H. J.
Chung, J. S.
Moon, J. H.
Chae, Y. S.
Ahn, J. S.
Yang, D. H.
Kim, H. J.
CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S81 - S81
[40] A Phase 1 Trial of Ruxolitinib, Lena-lidomide and Methylprednisolone for Patients with Relapsed/Refractory Multiple Myeloma (MM)
Berenson, James
To, Jennifer
Spektor, Tanya
Martinez, Daisy
Sanchez, Armando
Ghermezi, Matthew
Turner, Carley
Swift, Regina
Eades, Benjamin
Schwartz, Gary
Eshaghian, Shahrooz
Stampleman, Laura
Moss, Robert
Nassir, Youram
Patel, Ravindranath
Bessudo, Alberto
Lim, Stephen
Vescio, Robert
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E249 - E249

← 1 2 3 4 5 →